Shattuck Labs, Inc.
Shattuck Labs, Inc.
Your view on STTK
Overview
What the company does, where it operates, and who runs it.
About Shattuck Labs, Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Taylor H. Schreiber
- Headquarters
- 500 West 5th Street, Austin, TX, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Taylor H. Schreiber
- Headquarters
- 500 West 5th Street, Austin, TX, US
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. The company was incorporated in 2016 and is headquartered in Austin, Texas.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.